FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HEALY JAMES 		2. Issuer Name and Ticker or Trading Symbol

INTERMUNE INC [ ITMN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

3280 BAYSHORE BLVD 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/29/2014
(Street)

BRISBANE, CA 94005
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock   9/29/2014     D (1)    13549   D $74.00   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted stock units   $0.00   9/29/2014     D         4000      (2)   (2) Common stock   4000   $0.00   0   D    
Stock options (right to buy)   $13.26   9/29/2014     D         8335      (3) 1/1/2015   Common stock   8335   $0.00   0   D    
Stock options (right to buy)   $11.95   9/29/2014     D         20000      (3) 5/27/2015   Common stock   20000   $0.00   0   D    
Stock options (right to buy)   $14.41   9/29/2014     D         20000      (3) 5/25/2016   Common stock   20000   $0.00   0   D    
Stock options (right to buy)   $25.55   9/29/2014     D         12000      (3) 5/15/2017   Common stock   12000   $0.00   0   D    
Stock options (right to buy)   $15.34   9/29/2014     D         12000      (3) 5/13/2015   Common stock   12000   $0.00   0   D    
Stock options (right to buy)   $11.33   9/29/2014     D         12000      (3) 5/21/2019   Common stock   12000   $0.00   0   D    
Stock options (right to buy)   $10.37   9/29/2014     D         12000      (3) 5/10/2020   Common stock   12000   $0.00   0   D    
Stock options (right to buy)   $39.46   9/29/2014     D         12000      (3) 5/9/2021   Common stock   12000   $0.00   0   D    
Stock options (right to buy)   $10.10   9/29/2014     D         6000      (3) 6/3/2022   Common stock   6000   $0.00   0   D    
Stock options (right to buy)   $9.99   9/29/2014     D         6000      (3) 5/29/2020   Common stock   6000   $0.00   0   D    
Stock options (right to buy)   $40.26   9/29/2014     D         8000      (3) 5/28/2021   Common stock   8000   $0.00   0   D    

Explanation of Responses:
( 1)  Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 22, 2014 (the "Merger Agreement"), among InterMune, Inc. ("InterMune"), Roche Holdings, Inc. ("Roche") and Klee Acquisition Corporation, on September 29, 2014, each share of InterMune common stock, par value $0.001 ("Common Stock") and all InterMune restricted shares issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement), other than shares of Common Stock owned by InterMune, any subsidiary of InterMune, Roche, Klee Acquisition Corporation and any other subsidiary of Roche, and shares of Common Stock owned by stockholders who have validly exercised their statutory rights of appraisal, were converted into the right to receive $74.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes.
( 2)  Pursuant to the Merger Agreement, on September 29, 2014, each InterMune restricted stock unit subject to service-based vesting conditions outstanding immediately prior to the Effective Time was canceled and converted into the right to receive the Merger Consideration, subject to any required withholding taxes.
( 3)  Pursuant to the Merger Agreement, on September 29, 2014, each InterMune stock option outstanding at the Effective Time, whether or not vested, was canceled and converted into the right to receive the excess, if any, of the Merger Consideration over the exercise price per share of the stock option, subject to any required withholding taxes.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HEALY JAMES
3280 BAYSHORE BLVD
BRISBANE, CA 94005 		X



Signatures
By: /s/ John Hodgman, Attorney-in-fact for: James I. Healy 10/1/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
(MM) (NASDAQ:ITMN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more (MM) Charts.
(MM) (NASDAQ:ITMN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more (MM) Charts.